Results 131 to 140 of about 1,195,438 (288)
INTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDES IN IMMUNOGLOBULIN-DEFICIENT SERA [PDF]
H Gewurz+5 more
openalex +1 more source
Abstract Purpose This work introduces BreastWatch, a Varian Eclipse script tool designed to help medical physicists, dosimetrists, and radiation oncologists easily inspect and improve External Beam Breast Treatment (EBBT) plans using automatic evaluation of protocol dose‐constraints enhanced by a Community‐Based approach.
Stefano Agostinelli+8 more
wiley +1 more source
The kinetics of haemolysis in amboceptor-complement systems
Eric Ponder
openalex +1 more source
Humoral immune system in inflammatory bowel disease: I. Complement levels. [PDF]
H J Hodgson, Barry J. Potter, D P Jewell
openalex +1 more source
Abstract Purpose Volumetric‐modulated arc therapy (VMAT) treatment planning allows a compromise between a sufficient coverage of the planning target volume (PTV) and a simultaneous sparing of organs‐at‐risk (OARs). Particularly in the case of lung tumors, deciding whether it is possible or worth spending more time on further improvements of a treatment
Johann Brand+4 more
wiley +1 more source
Guangjiang Wang, Yuan Guo Department of Ophthalmology, The Fourth Hospital of Baotou, Baotou City, Inner Mongolia Autonomous Region, 014030, People’s Republic of ChinaCorrespondence: Yuan Guo, Department of Ophthalmology, The Fourth Hospital of Baotou ...
Wang G, Guo Y
doaj
Abstract Purpose An evaluation of the accuracy, safety, and efficiency of the Halcyon ring delivery system (RDS) for stereotactic radiosurgery (SRS) treatment to relatively small (1–3 cm) brain lesions. Methods After completing the extensive in‐house quality assurance checks including Winston–Lutz test and independent dose verification via MD Anderson ...
Kate Hazelwood+5 more
wiley +1 more source
Specific enhancement of the cytotoxic titre with regard to complement source and cytotoxicity test systems [PDF]
H.-D. Adolphs
openalex +1 more source
Abstract Objectives An increasing body of evidence indicates altered DNA methylation in Parkinson's disease, yet the reproducibility and utility of such methylation changes are largely unexplored. We aimed to further elucidate the role of dysregulated DNA methylation in Parkinson's disease and to evaluate the biomarker potential of methylation‐based ...
Ingeborg Haugesag Lie+4 more
wiley +1 more source
Editorial: Current challenges in complement diagnostics
Per H. Nilsson+4 more
doaj +1 more source